Angiotensin II regulates brain (Pro)renin receptor expression through activation of cAMP response element-binding protein

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 2, 2015, Pages R138-R147

  Li, Wencheng ^a   Liu, Jiao ^b   Hammond, Sean L ^a   Tjalkens, Ronald B ^a   Saifudeen, Zubaida ^b   Feng, Yumei ^c  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

(Pro)renin receptor; CAMP response element binding protein; Central nervous system; Renin angiotensin system; Salt sensitive hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BRAIN RECEPTOR; CAPTOPRIL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LOSARTAN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; PRORENIN RECEPTOR; PROTEIN C JUN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATP6AP2 PROTEIN, MOUSE; CELL SURFACE RECEPTOR; CREBBP PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BINDING SITE; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA INTERFERENCE; TIME;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BINDING SITES; CELL LINE; CREB-BINDING PROTEIN; DESOXYCORTICOSTERONE ACETATE; DISEASE MODELS, ANIMAL; HYPERTENSION; INFUSIONS, INTRAVENTRICULAR; MICE, INBRED C57BL; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTON-TRANSLOCATING ATPASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, CELL SURFACE; RENIN-ANGIOTENSIN SYSTEM; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UP-REGULATION;

EID: 84937414926     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00319.2014     Document Type: Article

References (29)

1. Best JL, Amezcua CA, Mayr B, Flechner L, Murawsky CM, Emerson B, Zor T, Gardner KH, Montminy M. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc Natl Acad Sci USA 101: 622–627, 2004.
2. Blume A, Herdegen T, Unger T. Angiotensin peptides and inducible transcription factors. J Mol Med (Berl) 77: 339–357, 1999.
3. Cardinaux JR, Notis JC, Zhang Q, Vo N, Craig JC, Fass DM, Brennan RG, Goodman RH. Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol Cell Biol 20: 1546–1552, 2000.
4. Davisson RL, Yang GY, Beltz TG, Cassell MD, Johnson AK, Sigmund CD. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 83: 1047–1058, 1998.
5. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu XP, Pfahl M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372: 107–111, 1994.
6. Funakoshi Y, Ichiki T, Takeda K, Tokuno T, Iino N, Takeshita A. Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 277: 710–717, 2002.
7. Haack KK, Mitra AK, Zucker IH. NF-_B and CREB are required for angiotensin II type 1 receptor upregulation in neurons. PLoS One 8: e78695, 2013.
8. Hayashi J, Takeda K, Kawasaki S, Nakamura Y, Oguro M, Nakata T, Tanabe S, Lee LC, Sasaki S, Nakagawa M. Central attenuation of baroreflex by angiotensin II in normotensive and spontaneously hypertensive rats. Am J Hypertens 1: 15S–22S, 1988.
9. Huang J, Siragy HM. Sodium depletion enhances renal expression of (pro)renin receptor via cyclic GMP-protein kinase G signaling pathway. Hypertension 59: 317–323, 2012.
10. Huang Y, Noble NA, Zhang J, Xu C, Border WA. Renin-stimulated TGF-_1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 72: 45–52, 2007.
11. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763–1774, 2010.
12. Iyer A, Fenning A, Lim J, Le GT, Reid RC, Halili MA, Fairlie DP, Brown L. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol 159: 1408–1417, 2010.
13. Kee HJ, Bae EH, Park S, Lee KE, Suh SH, Kim SW, Jeong MH. HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCAsalt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activity. Kidney Blood Press Res 37: 229–239, 2013.
14. La Porta CA, Comolli R. PKC-dependent modulation of IkB _-NF-_B pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res 18: 2591–2597, 1998.
15. Li BX, Xiao X. Discovery of a small-molecule inhibitor of the KIX-KID interaction. Chembiochem 10: 2721–2724, 2009.
16. Li W, Peng H, Cao T, Sato R, McDaniels SJ, Kobori H, Navar LG, Feng Y. Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension 59: 1188–1194, 2012.
17. Li W, Peng H, Mehaffey EP, Kimball CD, Grobe JL, van Gool JM, Sullivan MN, Earley S, Danser AH, Ichihara A, Feng Y. Neuronspecific (pro)renin receptor knockout prevents the development of saltsensitive hypertension. Hypertension 63: 316–323, 2014.
18. Li W, Peng H, Seth DM, Feng Y. The prorenin and (pro)renin receptor: new players in the brain renin-angiotensin system? Int J Hypertens 2012: 290-635, 2012.
19. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99: 1004–1011, 2006.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta CT) method. Methods 25: 402–408, 2001.
21. Ma R, Schultz HD, Wang W. Chronic central infusion of ANG II potentiates cardiac sympathetic afferent reflex in dogs. Am J Physiol Heart Circ Physiol 277: H15–H22, 1999.
22. Manna PR, Stocco DM. Crosstalk of CREB and Fos/Jun on a single cis-element: transcriptional repression of the steroidogenic acute regulatory protein gene. J Mol Endocrinol 39: 261–277, 2007.
23. Miller JA, Trout BR, Sullivan KA, Bialecki RA, Roberts RA, Tjalkens RB. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-_B reporter mice prior to loss of dopaminergic neurons. J Neurosci Res 89: 406–417, 2011.
24. Nguyen G. The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology. Curr Opin Nephrol Hypertens 16: 129–133, 2007.
25. Peng H, Li W, Seth DM, Nair AR, Francis J, Feng Y. (Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells. PLoS One 8: e58339, 2013.
26. Shan Z, Cuadra AE, Sumners C, Raizada MK. Characterization of a functional (pro)renin receptor in rat brain neurons. Exp Physiol 93: 701–708, 2008.
27. Shan Z, Shi P, Cuadra AE, Dong Y, Lamont GJ, Li Q, Seth DM, Navar LG, Katovich MJ, Sumners C, Raizada MK. Involvement of the brain (pro)renin receptor in cardiovascular homeostasis. Circ Res 107: 934–108, 2010.
28. Siragy HM, Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 93: 709–714, 2008.
29. Zhang Y, Wu J, Wang X, Morgan T. Effects of enalapril and sodium depletion on the renin-angiotensin system in hydronephrotic mice. Can J Physiol Pharmacol 87: 515–521, 2009.